Vital KSK Holdings, Inc.

Tokyo Stock Exchange 3151.T

Vital KSK Holdings, Inc. Shareholders' Equity for the year ending March 31, 2024: USD 691.51 M

Vital KSK Holdings, Inc. Shareholders' Equity is USD 691.51 M for the year ending March 31, 2024, a -7.19% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Vital KSK Holdings, Inc. Shareholders' Equity for the year ending March 31, 2023 was USD 745.06 M, a -8.35% change year over year.
Vital KSK Holdings, Inc. Shareholders' Equity for the year ending March 31, 2022 was USD 812.96 M, a -12.55% change year over year.
Vital KSK Holdings, Inc. Shareholders' Equity for the year ending March 31, 2021 was USD 929.58 M, a 3.76% change year over year.
Vital KSK Holdings, Inc. Shareholders' Equity for the year ending March 31, 2020 was USD 895.89 M, a 3.44% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

Tokyo Stock Exchange: 3151.T

Vital KSK Holdings, Inc.

CEO	Mr. Taisuke Murai
IPO Date	Jan. 1, 2001
Location	Japan
Headquarters	1-1-12, Tsurumaki
Employees	3,705
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies Retail & Wholesale

Description

Vital KSK Holdings, Inc. engages in the wholesale of pharmaceutical products in Japan. The company is involved in the wholesale of veterinary drugs; agricultural chemicals, agricultural materials, etc.; and medical and nursing care equipment. It also engages in the pharmacy and nursing care businesses; transportation business; insurance agent and real estate management businesses; parking business; mail-order business of health-related products; and pharmacy dispensing business. In addition, the company offers medical management consulting services; and manufactures OTC drugs. The company was founded in 2009 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years